Bayer logo

Bayer

Last updated January 31, 2026
432
Innovation Areas
13,147
Inventors
104
Collaborations

Aqueous isoxazolidinone suspension concentrates: BayerRecent Research Landscape

Active ingredient instability in liquid phases leads to rapid chemical degradation and reduced shelf-life. This lever utilizes emulsion polymer matrices to maintain structural integrity of the isoxazolidinone compound within aqueous concentrates.

What technical problems is Bayer addressing in Aqueous isoxazolidinone suspension concentrates?

Active ingredient chemical instability

(22)evidences

Off-target movement of liquid formulations during application leads to environmental contamination and reduced efficacy. Minimizing drift ensures precise delivery and regulatory compliance.

Active ingredient physical instability

(15)evidences

Suspension concentrates frequently suffer from phase separation, sedimentation, or crystal growth during storage. Preventing these degradation mechanisms ensures consistent dosage and long-term product efficacy.

Active ingredient chemical degradation

(9)evidences

Corrosive interactions and carrier fluid instability lead to the breakdown of sensitive chemical compounds. Preventing this degradation ensures long-term shelf stability and bio-efficacy.